News and Announcements
New NZ-based equity funds to hit market
- Published November 20, 2013 1:37PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Friday, 15 November 2013,
Press Release: Castle Point
A new joint venture, involving the ex-Tower Investments equity team, is launching two New Zealand funds targeting Trans-Tasman equities.
Castle Point will launch the Castle Point Ranger Fund and Castle Point Trans-Tasman Fund to meet growing New Zealand demand for diversified investment opportunities as KiwiSaver schemes expand and capital markets deepen.
The new boutique fund manager is headed by Richard Stubbs and Stephen Bennie and includes equity analysts, Jamie Young and Gordon Sims. This represents the entire equity team from Tower who have a top-quartile three-year track record recognised by this year’s finalist placing in the INFINZ Fund Manager of the Year awards.
Castle Point is backed by an equity stake taken by the principals of NZAM, the 22-year Absolute Returns global investment specialists. Capital backing is provided by RAW Capital Partners, a Guernsey-based asset manager whose principals include Richard Avery Wright and Dennis Stoller.
To read the full release please click here.
For more press coverage please click here on www.stuff.co.nz or here on www.radionz.co.nz.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
